Australia's largest stock trading and investment forum Australia's #1 stock forum

PNV

0.00%

$2.58 polynovo limited

Ann: FY24 Results Presentation, page-8

First 8 Last

Share
Profile

Follow
marley11

293 Posts.

12

20/08/24

07:44

Post #: 75278299
Share

Originally posted by Sojourner: ↑

I'm really looking forward to this presentation. Despite the challenges of having to compound results on bigger and bigger numbers, the company has been increasing its rate of growth.

I continue to be amazed at how well the company is doing outside of the U.S. Sales outside of the U.S have traditionally been very challenging for new companies like Polynovo without an existing footprint, trying to navigate different markets outside of the U.S. So much so, that it is not unusual to see the growth rates for a new company like PNV to have growth rates in the rest of the world significantly lower than the growth rates in the U.S. This has not been the case for PNV, and I think a significant factor behind this success has been driven by surgeons themselves who have been publishing their papers on their use of BTM.

Despite PNV being an ASX200 company, this has not been widely held be institutions. I am only aware of two smaller fund managers holding this stock. I think this is set to change in the very near future (<12 months) for a number of reasons:

1. The stock has already passed its breakeven point and is likely to continue to grow profitability despite it not being a priority at all.
2. There is clear strategy being developed to expand the range of products the company has to address other market needs - each with its own massive underserved markets. It would also show the market more clearly that it is not a one product company
3. Consolidation of the company's product as 'the standard of care'. Unfortunately, there has been a long standing view from analysts that the company is still the little unknown upstart against the 400 pound gorilla, and that you needed to discount the stock heavily, given the inertia of its customers to move. I think the company has beyond proving this view incorrect, and when the broader market comes to that realisation, it would support a very quick jump in the stock price.
4. Consistent growth. In the few years around and after covid, the company's growth trajectory was inconsistent. This has been changing as the company has been delivering very good growth over a number of reporting periods - is it enough to change the mind of the market? Maybe it is, maybe the market will want another half, who knows for sure? What I do know is that the results for the past 18 months have been excellent and compelling.

At the end of the day, what matters is the company's ability to continue to grow and sustain that growth. The latest unaudited results shows that it is continue very well along that path, and there are a number of other catalysts I have not mentioned such as the BARDA trials, expansion into India etc, but those are additional factors that can further add fuel to the fire.

It would not be surprised if Christmas comes and we're at over $4.

Expand

thank you so much

great summary

PNV Price at posting: $2.58 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MND

Monadelphous profits up 16.2% on strong revenue result, and the market likes it

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

INA

Ingenia shares jump 7% on strong revenue and earnings figures

UNT

UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off

KOB

Koba jumps on uranium rock chips grading over 7% as uranium price revival evidence mounts

There are more pages in this discussion • 1 more message in this thread...

First 8 Last

Add PNV (ASX) to my watchlist

(20min delay)
Last $2.58		Change 0.000(0.00%)		Mkt cap ! $1.780B

Open	High	Low	Value	Volume
$2.60	$2.61	$2.57	$900.5K	348.0K

Buyers (Bids)

No.	Vol.	Price($)
25	43698	$2.57

Sellers (Offers)

Price($)	Vol.	No.
$2.58	16327	29

View Market Depth

No.	Vol.	Price($)
20	43267	2.570
16	24778	2.560
18	62706	2.550
8	12918	2.540
4	7224	2.530

Price($)	Vol.	No.
2.580	13585	23
2.590	57021	20
2.600	76849	20
2.610	51148	19
2.620	86950	13

Last trade - 13.46pm 20/08/2024 (20 minute delay)

PNV (ASX) Chart

Ann: FY24 Results Presentation, page-8

Monadelphous profits up 16.2% on strong revenue result, and the market likes it

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Ingenia shares jump 7% on strong revenue and earnings figures

UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off

Koba jumps on uranium rock chips grading over 7% as uranium price revival evidence mounts

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: FY24 Results Presentation, page-8

Top Stories

Monadelphous profits up 16.2% on strong revenue result, and the market likes it

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Ingenia shares jump 7% on strong revenue and earnings figures

UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off

Koba jumps on uranium rock chips grading over 7% as uranium price revival evidence mounts

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News